News

Technology News

Codiak BioSciences Bags $80 Million Venture Capital

Thursday, November 19, 2015 5:02:00 AM PDT | VentureDeal
   Cambridge, Massachusetts  --  Biotechnology company Codiak BioSciences has secured $80 million in its first round of institutional venture capital financing commitments.

Codiak is developing exosome technology for cancer diagnostic purposes.

Investors in the round included Fidelity Management & Research Company, Alaska Permanent Fund and Alexandria Venture Investments.

The company did not specify how the funding proceeds would be used.

Concurrent with the announcement, Codiak said that Douglas Williams has joined the firm as its founding president and chief executive officer. He previously served as executive vice president at Biogen.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1